Russell Investments Group’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,017
| Closed | -$13K | – | 2994 |
|
|
2022
Q1 | $13K | Hold |
2,017
| – | – | ﹤0.01% | 2701 |
|
|
2021
Q4 | $16K | Hold |
2,017
| – | – | ﹤0.01% | 2964 |
|
|
2021
Q3 | $14K | Hold |
2,017
| – | – | ﹤0.01% | 3009 |
|
|
2021
Q2 | $13K | Sell |
2,017
-33,809
| -94% | -$218K | ﹤0.01% | 3184 |
|
|
2021
Q1 | $367K | Sell |
35,826
-36,512
| -50% | -$374K | ﹤0.01% | 2643 |
|
|
2020
Q4 | $504K | Sell |
72,338
-115,792
| -62% | -$807K | ﹤0.01% | 2423 |
|
|
2020
Q3 | $1.54M | Sell |
188,130
-22,795
| -11% | -$186K | ﹤0.01% | 1854 |
|
|
2020
Q2 | $1.46M | Sell |
210,925
-19,174
| -8% | -$133K | ﹤0.01% | 1829 |
|
|
2020
Q1 | $1.1M | Buy |
230,099
+147,794
| +180% | +$709K | ﹤0.01% | 1791 |
|
|
2019
Q4 | $698K | Buy |
82,305
+48,470
| +143% | +$411K | ﹤0.01% | 2282 |
|
|
2019
Q3 | $113K | Buy |
+33,835
| New | +$113K | ﹤0.01% | 2802 |
|
|
2018
Q4 | – | Sell |
-83,478
| Closed | -$543K | – | 3063 |
|
|
2018
Q3 | $543K | Buy |
83,478
+63,512
| +318% | +$413K | ﹤0.01% | 2354 |
|
|
2018
Q2 | $153K | Hold |
19,966
| – | – | ﹤0.01% | 2692 |
|
|
2018
Q1 | $446K | Sell |
19,966
-12,258
| -38% | -$274K | ﹤0.01% | 2504 |
|
|
2017
Q4 | $421K | Hold |
32,224
| – | – | ﹤0.01% | 2490 |
|
|
2017
Q3 | $502K | Buy |
+32,224
| New | +$502K | ﹤0.01% | 2441 |
|